Page 93 - Read Online
P. 93

Corn et al. J Cancer Metastasis Treat 2021;7:41  https://dx.doi.org/10.20517/2394-4722.2021.63  Page 15 of 19

               4.       Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006;16:1054-65.
                    DOI  PubMed
               5.       Albano D, Treglia G, Giovanella L, Giubbini R, Bertagna F. Detection of thyroiditis on PET/CT imaging: a systematic review.
                    Hormones (Athens) 2020;19:341-9.  DOI  PubMed
               6.       Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and
                    inflammation. Semin Nucl Med 2002;32:47-59.  DOI  PubMed
               7.       Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET:
                    histopathologic comparison. Radiology 2004;230:417-22.  DOI  PubMed
               8.       Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005;46:752-7.
                    PubMed
               9.       Dong C, Hemminki K. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-
                    1996: a search for common mechanisms. Br J Cancer 2001;85:997-1005.  DOI  PubMed  PMC
               10.       Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. Multiple primary cancer: an experience at the Cancer Institute Hospital
                    with special reference to colorectal cancer. Int J Clin Oncol 2003;8:162-7.  DOI  PubMed
               11.       Kang  KW,  Kim  SK,  Kang  HS,  et  al.  Prevalence  and  risk  of  cancer  of  focal  thyroid  incidentaloma  identified  by  18F-
                    fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin
                    Endocrinol Metab 2003;88:4100-4.  DOI  PubMed
               12.       Yang Z, Shi W, Zhu B, et al. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose
                    positron emission tomography/computed tomography. J Otolaryngol Head Neck Surg 2012;41:327-33.  PubMed
               13.       Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population.  Radiology
                    1991;181:683-7.  DOI  PubMed
               14.       Bartolotta TV, Midiri M, Runza G, et al. Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler
                    pattern in an adult population screened by real-time compound spatial sonography. Radiol Med 2006;111:989-98.  DOI  PubMed
               15.       Moon JH, Hyun MK, Lee JY, et al. Prevalence of thyroid nodules and their associated clinical parameters: a large-scale, multicenter-
                    based health checkup study. Korean J Intern Med 2018;33:753-62.  DOI  PubMed  PMC
               16.       Choi JY, Lee KS, Kim HJ, et al. , Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance
                    and improved characterization. J Nucl Med 2006;47:609-15.  PubMed
               17.       Kang HW, No JH, Chung JH, et al. Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid
                    2004;14:29-33.  DOI  PubMed
               18.       Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid "PETomas": clinical significance and novel description of the self-
                    resolving variant of focal FDG-PET thyroid uptake. Can J Surg 2011;54:83-8.  DOI  PubMed  PMC
               19.       Shetty SK, Maher MM, Hahn PF, Halpern EF, Aquino SL. Significance of incidental thyroid lesions detected on CT: correlation
                    among CT, sonography, and pathology. AJR Am J Roentgenol 2006;187:1349-56.  DOI  PubMed
               20.       Hosaka Y, Tawata M, Kurihara A, Ohtaka M, Endo T, Onaya T. The regulation of two distinct glucose transporter (GLUT1 and
                    GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 1992;131:159-65.  DOI  PubMed
               21.       Gould GW, Thomas HM, Jess TJ, Bell GI. Expression of human glucose transporters in Xenopus oocytes: kinetic characterization
                    and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 1991;30:5139-45.  DOI  PubMed
               22.       Pattison DA, Hofman MS. Role of fluorodeoxyglucose PET/computed tomography in targeted radionuclide therapy for endocrine
                    malignancies. PET Clin 2015;10:461-76.  DOI  PubMed
               23.       Gasparre G, Porcelli AM, Bonora E, et al. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic
                    phenotype in thyroid tumors. Proc Natl Acad Sci U S A 2007;104:9001-6.  DOI  PubMed  PMC
               24.       Kim BH, Kim SJ, Kim K, et al. High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node
                    metastasis in patients with incidentally detected thyroid carcinoma. Ann Nucl Med 2015;29:721-9.  DOI  PubMed  PMC
                                                            18
               25.       Ceriani L, Milan L, Virili C, et al. Radiomics analysis of [ F]-Fluorodeoxyglucose-avid thyroid incidentalomas improves risk
                    stratification and selection for clinical assessment. Thyroid 2021;31:88-95.  DOI  PubMed
               26.       Gedberg N, Karmisholt J, Gade M, Fisker RV, Iyer V, Petersen LJ. The frequency of focal thyroid incidental findings and risk of
                    malignancy detected by 18F-fluorodeoxyglucose positron emission tomography in an iodine deficient population. Diagnostics (Basel)
                    2018;8:46.  DOI  PubMed  PMC
               27.       Hassan A, Riaz S, Zafar W. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how
                    sinister are they? Nucl Med Commun 2016;37:1069-73.  DOI  PubMed
               28.       Even-Sapir E, Lerman H, Gutman M, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on
                    PET-CT. Eur J Nucl Med Mol Imaging 2006;33:541-52.  DOI  PubMed
               29.       Chun AR, Jo HM, Lee SH, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission
                    tomography. Endocrinol Metab (Seoul) 2015;30:71-7.  DOI  PubMed  PMC
               30.       Lee S, Park T, Park S, et al. The clinical role of dual-time-point (18)F-FDG PET/CT in differential diagnosis of the thyroid
                    incidentaloma. Nucl Med Mol Imaging 2014;48:121-9.  DOI  PubMed  PMC
               31.       Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose
                    positron emission tomography: a systematic review. Thyroid 2012;22:918-25.  DOI  PubMed
                                                                     18
               32.       Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A.  F-FDG-avid thyroid incidentalomas: the importance of
                    contextual interpretation. J Nucl Med 2018;59:749-55.  DOI  PubMed
               33.       Brindle R, Mullan D, Yap BK, Gandhi A. Thyroid incidentalomas discovered on positron emission tomography CT scanning -
   88   89   90   91   92   93   94   95   96   97   98